Evaluating the clinical feasibility: The direct bisulfite genomic sequencing for examination of methylated status of E3 ubiquitin ligase RNF180 DNA promoter to predict the survival of gastric cancer - Concepedia

Concepedia

Publication | Closed Access

Evaluating the clinical feasibility: The direct bisulfite genomic sequencing for examination of methylated status of E3 ubiquitin ligase RNF180 DNA promoter to predict the survival of gastric cancer

15

Citations

0

References

2015

Year

Xing-Ming Xie, Jing‐Yu Deng, Ya-Chao Hou, Jing-Li Cui, Wei-Peng Wu, GuoGuang Ying, Qiu-Ping Dong, Xi-Shan Hao, Han Liang

Cancer Biomarkers

Abstract

hypermethylated CpG site count of RNF180 DNA promoter for evaluating the prognosis of gastric cancer was reasonable by using the direct bisulfite sequencing.